Edwards’ Sapien M3 Gains European Approval
Edwards Lifesciences Corp. today announced that it received CE Mark approval, the European equivalent of the Food and Drug Administration, for its Sapien M3 mitral replacement system. The device replaces the mitral valve in patients with severe mitral regurgitation (MR). It’s said to be the world’s first approved transcatheter valve Read More